13F-HR filed by BRAIDWELL LP
BRAIDWELL LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 81 holding rows worth $3,032,008,157.
- Accession
- 0000905148-23-000454
- Filer
- CIK 1920938
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 81 entries on the cover page, a total value of $3,032,008,157 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,032,008,157 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC | 40131MAB5 | NOTE 11/1 | 250,022,000 | $168,847,260 | dollars as filed | principal |
| EXACT SCIENCES CORP | 30063PAC9 | NOTE 0.375% 3/0 | 139,000,000 | $122,748,869 | dollars as filed | principal |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 145,520,000 | $121,832,851 | dollars as filed | principal |
| NOVOCURE LTD | 67011XAB9 | NOTE 11/0 | 134,334,000 | $116,802,148 | dollars as filed | principal |
| ALPHATEC HLDGS INC | 02081GAB8 | NOTE 0.750% 8/0 | 101,250,000 | $108,210,938 | dollars as filed | principal |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 143,338,000 | $106,213,458 | dollars as filed | principal |
| NEVRO CORP | 64157FAC7 | NOTE 2.750% 4/0 | 109,251,000 | $102,695,940 | dollars as filed | principal |
| GLAUKOS CORP COM | 377322102 | Stock | 1,806,651 | $90,513,215 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 3,714,672 | $90,377,970 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 766,800 | $77,615,496 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 2,137,110 | $76,487,167 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 207,130 | $69,210,418 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 220,742 | $61,372,898 | dollars as filed | |
| NEVRO CORP | 64157F103 | COM | 1,632,915 | $59,029,877 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 223,120 | $57,000,466 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 454,169 | $56,330,581 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 982,241 | $54,534,020 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 56,031,000 | $53,901,491 | dollars as filed | principal |
| NUVASIVE INC | 670704AL9 | BOND | 51,500,000 | $51,148,812 | dollars as filed | principal |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 65,976,000 | $51,148,346 | dollars as filed | principal |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 3,241,351 | $50,078,873 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,319,978 | $49,472,775 | dollars as filed | |
| IONIS PHARMACEUTICALS INC | 462222AD2 | NOTE 4/0 | 52,740,000 | $48,125,250 | dollars as filed | principal |
| EXACT SCIENCES CORP | 30063PAB1 | NOTE 0.375% 3/1 | 48,300,000 | $45,183,667 | dollars as filed | principal |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 998,871 | $44,239,997 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 3,159,895 | $42,247,796 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 1,038,310 | $41,989,256 | dollars as filed | |
| AMYRIS INC | 03236MAJ0 | BOND | 137,850,000 | $39,080,475 | dollars as filed | principal |
| Amgen Inc. | 031162100 | COM | 161,500 | $39,042,625 | dollars as filed | |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 39,963,000 | $36,486,219 | dollars as filed | principal |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 48,678,000 | $36,021,720 | dollars as filed | principal |
| IONIS PHARMACEUTICALS INC | 462222AB6 | NOTE 0.125%12/1 | 36,533,000 | $33,800,477 | dollars as filed | principal |
| NUVASIVE INC | 670704AJ4 | NOTE 0.375% 3/1 | 36,665,000 | $32,466,858 | dollars as filed | principal |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 2,019,714 | $32,436,607 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 1,754,350 | $32,280,040 | dollars as filed | |
| NEOGENOMICS INC | 64049MAA8 | Convertible Debt | 33,000,000 | $30,958,125 | dollars as filed | principal |
| HARROW INC | 415858109 | COM | 1,452,538 | $30,735,704 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 107,044 | $29,832,092 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 4,126,194 | $29,708,597 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 601,801 | $29,018,844 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 984,800 | $28,214,520 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422GAA5 | CNV | 28,350,000 | $27,868,050 | dollars as filed | principal |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 348,036 | $27,863,762 | dollars as filed | |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 42,294,000 | $27,379,090 | dollars as filed | principal |
| MERUS N V | N5749R100 | COM | 1,473,084 | $27,104,746 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 1,620,216 | $26,782,170 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 3,269,094 | $26,446,970 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 1,997,055 | $23,645,131 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 973,073 | $21,174,068 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 426,110 | $21,066,878 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 12,107,785 | $20,462,157 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 3,206,315 | $19,847,090 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 920,049 | $19,431,435 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 335,200 | $18,985,728 | dollars as filed | |
| PARAGON 28 INC | 69913P105 | COM | 1,098,722 | $18,755,185 | dollars as filed | |
| STERIS PLC SHS USD | G8473T100 | Stock | 95,694 | $18,304,348 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 452,000 | $16,805,360 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,945,134 | $16,222,418 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,377,872 | $15,873,085 | dollars as filed | |
| INVITAE CORP | 46185LAB9 | NOTE 2.000% 9/0 | 16,781,000 | $14,842,012 | dollars as filed | principal |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 604,036 | $14,055,918 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 3,355,805 | $13,792,359 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 1,163,294 | $13,005,627 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 1,097,300 | $12,706,734 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 3,247,847 | $10,620,460 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 333,800 | $10,284,378 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 24,600 | $9,165,468 | dollars as filed | |
| AXONICS INC | 05465P101 | COM | 166,704 | $9,095,370 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 550,300 | $8,617,698 | dollars as filed | |
| TRANSMEDICS GROUP INC | 89377M109 | COM | 98,459 | $7,456,300 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 4,122,900 | $6,844,014 | dollars as filed | |
| SUPERNUS PHARMACEUTICALS | 868459AD0 | BOND | 6,500,000 | $6,515,368 | dollars as filed | principal |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 648,451 | $5,725,822 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,249,900 | $5,649,548 | dollars as filed | |
| INSMED INC | 457669AB5 | NOTE 0.750% 6/0 | 3,500,000 | $2,721,080 | dollars as filed | principal |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 63,331 | $2,478,142 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 322,287 | $2,223,780 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,211,519 | $1,926,315 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 73,665 | $1,300,924 | dollars as filed | |
| ILLUMINA INC | 452327AK5 | NOTE 8/1 | 11,100,000 | $1,087,736 | dollars as filed | principal |
| AVALO THERAPEUTICS INC COM NEW | 05338F207 | Stock | 247,254 | $432,695 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000905148-23-000454 | this filing | 2023-05-15 | acceptance time not in the bulk data set |